文档介绍：Acta Psychiatr Scand 2006: 113: 408–419 Copyright Ó 2006 The Authors
All rights reserved pilation Ó 2006 Blackwell Munksgaard
DOI: -
ACTA PSYCHIATRICA
SCANDINAVICA
Cognitive behaviour therapy and medication
in the treatment of pulsive
disorder
O’Connor KP, Aardema F, Robillard S, Guay S, Pe´lissier M-C, K. P. O'Connor1, F. Aardema1,
Todorov C, Borgeat F, Leblanc V, Grenier S, Doucet P. Cognitive S. Robillard1, S. Guay1, M.-C.
behaviour therapy and medication in the treatment of obsessive– PØlissier1, C. Todorov2, F. Borgeat2,
compulsive disorder. V. Leblanc1, S. Grenier1, P. Doucet1
1Fernand-Seguin Research Centre, Louis-H. Lafontaine
Objective: pare cognitive behaviour therapy (CBT) with CBT Hospital, Montreal, QC, Canada and 2Louis-H.
plus medication; medication alone; and placebo in the treatment of Lafontaine Hospital, Montreal, QC, Canada
adult pulsive disorder (OCD).
Method: Forty-eight participants (pleters) were recruited into
two protocols. In the first protocol, 21 people with OCD were
randomly allocated to either a standard medication (fluvoxamine) or
standard placebo condition for a 5-month period. Both these groups
subsequently received CBT for a further 5 months. In the second
protocol, 22 people with OCD received CBT, one group was already
stabilized on an antidepressant of choice; the second group was drug
naı¨ve. Key words: cognitive therapy; cognitive behaviour;
Results: All active treatments, but not the placebo, showed clinical drug therapy; obsessive behaviour; anxiety; depression
improvement. There was no difference in treatment response to CBT Kieron O'Connor, Fernand-Seguin Research Centre,
regardless of whether participants had previously received medication Louis-H. Lafontaine Hospital, 7331 Hochelaga St.,
or placebo. Montreal, QC, Canada H1N 3V2.
Conclusion: CBT has a more specific antiobsessional effect than E-mail: kieron.******@
medication but CB